Union européenne #6009 (v.2)

Export authorisation for COVID-19 vaccines

Commission Implementing Regulation (EU) 2021/442 of 12 March 2021 making the exportation of certain products subject to the production of an export authorisation;
Official Journal L 85, 12.03.2021

https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32021R0442&from=EN


Application period: from 13.03.2021 until 30.06.2021

Administration: Competent authorities in EU Member States

Exemptions include
(see Article 1.5 of the regulation):

- exports in the context of humanitarian aid;

- exports to low and middle income countries in the COVAX Advance Market Commitment (AMC) list (https://www.gavi.org/news/media-room/92-low-middle-income-economies-eligible-access-covid-19-vaccines-gavi-covax-amc );

exports of goods purchased and/or delivered through COVAX, UNICEF and PAHO with destination to any other COVAX participating country;


- Albania, Algeria, Andorra, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Egypt, Faeroe Islands, Georgia, Holy See, Iceland, Israel, Jordan, Kosovo(see Footnote 1) , Lebanon, Libya, Liechtenstein, Moldova, Montenegro, Morocco, Norway, North Macedonia, Palestine(see Footnote 2) , San Marino, Serbia, Switzerland, Syria, Tunisia, Ukraine;

- EU overseas countries and territories

Footnote 1:This designation is without prejudice to positions on status, and is in line with UNSCR 1244/1999 and the ICJ Opinion on the Kosovo declaration of independence.
Footnote 2: This designation shall not be construed as recognition of a State of Palestine and is without prejudice to the individual positions of the EU Member States on this issue.

HS 2017